Melanie Ann Alarcio
Neurology with Special Qualifications in Child Neurology · Mesa, AZNPI 1578763751
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.9% of the total across 550 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by UCB, Inc. at 27.1% of the total.
Across 550 payments — averaging $18.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$3K
- Grifols USA, LLC$794
- Jazz Pharmaceuticals Inc.$758
- Neurelis, Inc.$715
- CSL Behring$659
- SK Life Science, Inc.$630
- plus $4K from 26 others
What the payments were for
- Food & beverage$9,86897%
- Education$3153%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 163 | $2,759 |
| Grifols USA, LLC | 22 | $794 |
| Jazz Pharmaceuticals Inc. | 28 | $758 |
| Neurelis, Inc. | 31 | $715 |
| CSL Behring | 31 | $659 |
| SK Life Science, Inc. | 27 | $630 |
| Sunovion Pharmaceuticals Inc. | 52 | $580 |
| Travere Therapeutics, Inc. | 69 | $537 |
| Sumitomo Pharma America, Inc. | 28 | $523 |
| Harmony Biosciences LLC | 10 | $332 |
| Greenwich Biosciences, Inc. | 10 | $290 |
| Mallinckrodt Hospital Products Inc. | 12 | $245 |
| Eisai Inc. | 5 | $162 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $158 |
| Livanova USA, Inc. | 10 | $155 |
| Catalyst Pharmaceuticals, Inc. | 5 | $133 |
| Kedrion Biopharma, Inc. | 5 | $99 |
| Zogenix Inc. | 5 | $99 |
| Romark Laboratories, LC | 5 | $89 |
| Aquestive Therapeutics, Inc. | 5 | $86 |
| Alnylam Pharmaceuticals Inc. | 2 | $55 |
| Bio Products Laboratory USA, Inc. | 3 | $52 |
| Zevra Therapeutics Inc | 2 | $48 |
| Biomarin Pharmaceutical Inc. | 2 | $41 |
| Amneal Pharmaceuticals LLC | 2 | $41 |
| Medtronic | 2 | $30 |
| Mallinckrodt Enterprises LLC | 2 | $25 |
| Argenx US, Inc. | 1 | $24 |
| Pharming Healthcare, Inc. | 1 | $21 |
| Sanofi | 1 | $16 |
| Otto Bock Healthcare LP | 1 | $15 |
| Terumo BCT, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,183 in reported general payments places this provider in the 80th percentile of 49 neurology with special qualifications in child neurology providers in Arizona.
See all neurology with special qualifications in child neurology providers in Arizona →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 22 | $162,214 |
| Famciclovir | 24 | $2,351 |
| Azithromycin | 12 | $1,480 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| CSL BehringHizentra | $659 | $162,21422 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 49 neurology with special qualifications in child neurology providers in Arizona.
Other neurology with special qualifications in child neurology in Mesa
- Nadeem ShabbirMesa$1K
- Jennifer YuenMesa$406
- Siddharth JainMesa$371
- Angus WilfongPhoenix$348K
- Clara ChowPhoenix$35K
- Dinesh TalwarTucson$30K
- Saunder BernesPhoenix$27K
- Randa JarrarPhoenix$25K
- Jeffrey BuchhalterPhoenix$19K
- Korwyn WilliamsPhoenix$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.